This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Poulain, M. Articles by Maltais, F. Search for Related Content PubMed PubMed Citation Articles by Poulain, M. Articles by Maltais, F. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information COPD (Chronic Obstructive Pulmonary Disease) Metabolic Syndrome Obesity Social Bookmarking                         What's this?

Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease

Clinique du Souffle, La Solane, 19 rue des Casteillets, 66340 Osséja, France, Division de Kinésiologie, Université Laval, Québec, Québec, Canada

M. Doucet

Centre de Recherche, Hôpital Laval, Institut Universitaire de Cardiologie et de Pneumologie de l'Université Laval, Québec, Québec, Canada

V. Drapeau

Division de Kinésiologie, Université Laval, Québec, Québec, Canada

G. Fournier

Division de Kinésiologie, Université Laval, Québec, Québec, Canada

A. Tremblay

Division de Kinésiologie, Université Laval, Québec, Québec, Canada

P. Poirier

Centre de Recherche, Hôpital Laval, Institut Universitaire de Cardiologie et de Pneumologie de l'Université Laval, Québec, Québec, Canada

F. Maltais

Centre de Recherche, Hôpital Laval, Institut Universitaire de Cardiologie et de Pneumologie de l'Université Laval, Québec, Québec, Canada, francois.maltais{at}med.ulaval.ca

Background: Overweight and obesity have been associated with better survival in patients with chronic obstructive pulmonary disease (COPD). On the other hand, excess body weight is associated with abnormal metabolic and inflammatory profiles that define the metabolic syndrome and predispose to cardiovascular diseases. This study was undertaken to evaluate the impact of overweight and obesity on the prevalence of the metabolic syndrome and on the metabolic and inflammatory profiles in patients with COPD.

Methods: Twenty-eight male patients with COPD were divided into an overweight/obese group [ n = 16, body mass index (BMI) = 33.5 ± 4.2 kg/m²] and normal weight group (n = 12, BMI = 21.1 ± 2.6kg/m²). Anthropometry, pulmonary function and body composition were assessed. The metabolic syndrome was diagnosed according to waist circumference, circulating levels of triglyceride and high-density lipoprotein cholesterol levels, fasting glycemia and blood pressure. C-reactive protein, tumor necrosis factor- (TNF-), interleukin-6 (IL-6), leptin and adiponectin plasma levels were measured.

Results: Airflow obstruction was less severe in overweight/obese compared with normal weight patients (forced expiratory volume₁: 51 ± 19% versus 31 ± 12% predicted, respectively, P < 0.01). The metabolic syndrome was diagnosed in 50% of overweight/obese patients and in none of the normal weight patients. TNF-, IL-6 and leptin were significantly higher in overweight/obese patients whereas the adiponectin levels were reduced in the presence of excess weight.

Conclusions: The metabolic syndrome was frequent in overweight/obese patients with COPD. Obesity in COPD was associated with a spectrum of metabolic and inflammatory abnormalities. Chronic Respiratory Disease 2008; 5: 35—41

Key Words: cardiovascular diseases • COPD • diabetes • inflammation • metabolic syndrome • obesity

Chronic Respiratory Disease, Vol. 5, No. 1, 35-41 (2008)
DOI: 10.1177/1479972307087205


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?